Magdalena Parys

Specializzazione: Nephrologist
Studio medico: Polonia, Varsavia, LUX MED Szpital św. Elżbiety
- Specialist at LUX MED Szpital św. Elżbiety in urology with a focus on prostate cancer and minimally invasive prostate procedures.
- First in Poland to perform a sequence of advanced treatments: TMA (2025), focal NanoKnife (2023), cryoablation (2022), REZUM (2020), and HOLEP (2018).
- Also performed ECIRS (2016) for kidney stone disease (combining PCNL and RIRS) and RIRS (2014) for kidney stones.
- Since then, trained 250+ doctors in performing these procedures in Poland and abroad.
Marek Zawadzki is a specialist at LUX MED Szpital św. Elżbiety in urology, with a track record of first-in-Poland advanced prostate and stone procedures. He performed TMA in 2025, focal NanoKnife in 2023, cryoablation in 2022, REZUM in 2020, and HOLEP in 2018. He has since trained 250+ physicians in Poland and abroad, making him a strong option for patients seeking modern, minimally invasive urologic treatment.

Com'è andata la tua esperienza?

1 di 3

Le informazioni su questo medico sono complete e chiare

Totalmente in disaccordo

Totalmente d'accordo

Formazione accademica

Marek Zawadzki is a specialist at LUX MED Szpital św. Elżbiety, recognized in the provided evidence for pioneering minimally invasive urologic procedures in Poland. His list of “firsts” includes TMA in 2025 for prostate cancer, focal NanoKnife in 2023 for prostate cancer, and cryoablation in 2022. He also performed REZUM in 2020 for benign prostatic hyperplasia and HOLEP in 2018. For kidney stone disease, the evidence highlights ECIRS in 2016 (combining PCNL and RIRS) and RIRS in 2014. Importantly for patients considering newer techniques, Zawadzki has trained more than 250 doctors in performing these procedures across Poland and abroad. His clinical scope in the provided evidence includes urolithiasis, prostate cancer, benign prostatic hyperplasia, bladder leukoplakia, and even nasopharyngeal cancer. The operative list includes TURP, TMA, focal NanoKnife ablation, cryoablation, REZUM, HOLEP, ECIRS, and RIRS.

Education

Warsaw Medical University (Warszawska Akademia Medyczna) — completed (year not specified).

Work experience

Not specified in the provided evidence.

Clinical focus and techniques

Zawadzki’s practice is built around modern, minimally invasive urology for prostate disease and kidney stones.

TMA (Targeted Microwave Therapy / transurethral microwave/thermal ablation) for prostate cancer (2025).
Focal NanoKnife ablation for prostate cancer (2023).
Cryoablation for prostate cancer (2022).
REZUM for benign prostatic hyperplasia (2020).
HOLEP for benign prostatic hyperplasia (2018).
ECIRS for kidney stone disease (2016).
RIRS for kidney stone disease (2014).
TURP (transurethral resection of the prostate).

Professional societies and certifications

Not specified in the provided evidence.

Academic output

Not specified in the provided evidence.

Courses and advanced training

Trained more than 250 doctors in performing the listed procedures in Poland and abroad.

Awards and recognition

Not specified in the provided evidence.

Zawadzki works at LUX MED Szpital św. Elżbiety in Warsaw. The evidence provided does not list consultation languages or online availability, but his profile is clearly oriented toward advanced urology procedures and physician training in modern techniques.